Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1.

Cytochromes P450 are responsible for metabolism of most xenobiotics and are required for the efficient elimination of foreign chemicals from the body. Paradoxically, these enzymes also metabolically activate biologically inert compounds to electrophilic derivatives that can cause toxicity, cell death and sometimes cellular transformation resulting in cancer. To establish the role of these enzymes in toxicity and carcinogenicity in vivo, gene knockout mice have been developed. To illustrate the role of P450s in toxicity, CYP2E1-null mice were employed with the commonly used analgesic drug acetaminophen. CYP2E1 is the rate-limiting enzyme that initiates the cascade of events leading to acetaminophen hepatotoxicity; in the absence of this P450, toxicity will only be apparent at high concentrations. Other enzymes and nuclear receptors are also involved in activation or inactivating chemicals. CYP2E1 is induced by alcohol and the primary P450 that carries out ethanol oxidation that can lead to the production of activated oxygen species and oxidative stress that elevate ERK1/2 phosphorylation through EGRF/c-Raf signaling. Paradoxically, activation of this pathway inhibits apoptotic cell death stimulated by reactive oxygen generating chemicals but accelerates necrotic cell death produced by polyunsaturated fatty acids. CYP2E1 is thought to contribute to liver pathologies that result from alcoholic liver disease and non-alcoholic steatohepatitis.

[1]  R. Evans,et al.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Lieber CYP2E1: from ASH to NASH. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  F Peter Guengerich,et al.  Cytochromes P450, drugs, and diseases. , 2003, Molecular interventions.

[4]  D. Moore,et al.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR) , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Guengerich,et al.  Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.

[6]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[7]  Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. , 2002, Alcoholism, clinical and experimental research.

[8]  A. Salter,et al.  Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia. , 1998, The Biochemical journal.

[9]  F Peter Guengerich,et al.  Functional characterization of four allelic variants of human cytochrome P450 1A2. , 2004, Archives of biochemistry and biophysics.

[10]  F. Gonzalez,et al.  Study of P450 function using gene knockout and transgenic mice. , 2003, Archives of biochemistry and biophysics.

[11]  Ai-Ming Yu,et al.  Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. , 2003, Pharmacogenetics.

[12]  T. Pineau,et al.  Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor , 1995, Science.

[13]  D. Moore,et al.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism , 2000, Nature.

[14]  Shelly C. Lu,et al.  Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Kenji Nakamura,et al.  Loss of teratogenic response to 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD) in mice lacking the Ah (dioxin) receptor , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[16]  T. Vanhaecke,et al.  Hepatocyte cultures in drug metabolism and toxicological research and testing. , 2006, Methods in molecular biology.

[17]  R S McCuskey,et al.  Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Shimada,et al.  Purification and characterization of human liver microsomal cytochrome P-450 2A6. , 1991, Molecular pharmacology.

[19]  L. Maltais,et al.  Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. , 2004, Pharmacogenetics.

[20]  D. Roop,et al.  Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione Toxicity* , 2002, The Journal of Biological Chemistry.

[21]  A. Cederbaum,et al.  Oxidative stress, toxicology, and pharmacology of CYP2E1. , 2004, Annual review of pharmacology and toxicology.

[22]  M. Ingelman-Sundberg,et al.  Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). , 1989, Biochemical pharmacology.

[23]  D. Nebert,et al.  Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. , 2000, Biochemical and biophysical research communications.

[24]  I. Leclercq,et al.  Central role of PPARα‐dependent hepatic lipid turnover in dietary steatohepatitis in mice , 2003, Hepatology.

[25]  B. Neuschwander‐Tetri,et al.  Humanized xenobiotic response in mice expressing nuclear receptor SXR , 2000, Nature.

[26]  T. Shimada,et al.  Activation of procarcinogens by human cytochrome P450 enzymes. , 1998, Mutation research.

[27]  C. Wolf,et al.  Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Jaiswal,et al.  Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione Toxicity* , 1998, The Journal of Biological Chemistry.

[29]  W. Chan,et al.  Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. , 1998, Toxicology and applied pharmacology.

[30]  T. Pineau,et al.  Role of CYP2E1 in the Hepatotoxicity of Acetaminophen (*) , 1996, The Journal of Biological Chemistry.

[31]  P. Watkins,et al.  THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS* , 2000, Drug metabolism reviews.

[32]  M. Ingelman-Sundberg,et al.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis , 1998, Hepatology.

[33]  A. Cederbaum,et al.  Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. , 1993, Biochemistry.

[34]  Wen Xie,et al.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Casazza,et al.  Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. , 1985, The Journal of biological chemistry.

[36]  L. Hui,et al.  Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. , 2002, Environmental health perspectives.

[37]  K. Hensley,et al.  Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. , 2002, Archives of biochemistry and biophysics.

[38]  D. WuDunn Genetic basis of glaucoma , 2002, Current opinion in ophthalmology.

[39]  C. Wolf,et al.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Reddy,et al.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  I. Leclercq,et al.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. , 2000, The Journal of clinical investigation.

[42]  J. Peters,et al.  Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor α , 1998 .

[43]  N. Chalasani,et al.  Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis , 2003, Hepatology.

[44]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[45]  M. Czaja,et al.  CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling , 2004, Hepatology.

[46]  J. Matés,et al.  Antioxidant enzymes and human diseases. , 1999, Clinical biochemistry.

[47]  T. Pineau,et al.  Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2. , 1996, Pharmacogenetics.

[48]  Lang Li,et al.  Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. , 2003, British journal of clinical pharmacology.

[49]  F. Gonzalez,et al.  Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation* , 2000, The Journal of Biological Chemistry.

[50]  F. Gonzalez,et al.  Transgenic models in xenobiotic metabolism and toxicology. , 2002, Toxicology.

[51]  H. Forman,et al.  Redox signaling and the MAP kinase pathways , 2003, BioFactors.

[52]  J M Ward,et al.  Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. , 1998, Toxicology and applied pharmacology.

[53]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  K. Korzekwa,et al.  Cytochromes P450 Expression Systems , 1995 .

[55]  A. Cederbaum,et al.  CYP2E1 Overexpression in HepG2 Cells Induces Glutathione Synthesis by Transcriptional Activation of γ-Glutamylcysteine Synthetase* , 2000, The Journal of Biological Chemistry.

[56]  J. Goldstein,et al.  Mouse Liver CYP2C39 Is a Novel Retinoic Acid 4-Hydroxylase , 2004, Journal of Biological Chemistry.

[57]  T. Willson,et al.  Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. , 2002, Journal of lipid research.

[58]  G. L. Kedderis,et al.  Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. , 1999, Toxicology and applied pharmacology.

[59]  Y. Liu,et al.  Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[60]  I. Leclercq,et al.  Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[61]  E. P. Dellinger,et al.  CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease , 2003, Hepatology.

[62]  K. Mak,et al.  Model of nonalcoholic steatohepatitis. , 2004, The American journal of clinical nutrition.

[63]  J. Ward,et al.  Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[64]  P. Valensi,et al.  Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation , 1998, Fundamental & clinical pharmacology.

[65]  F. Gonzalez,et al.  Targeted Disruption of the Microsomal Epoxide Hydrolase Gene , 1999, The Journal of Biological Chemistry.

[66]  F. Gonzalez,et al.  Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. , 1989, The Journal of biological chemistry.

[67]  D. Moore,et al.  Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR , 2002, Science.

[68]  M. Weltman,et al.  Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. , 1996, Gastroenterology.